The Long Run with Luke Timmerman
212 episodes — Page 5 of 5
Ep12: David Schenkein
Agios CEO David Schenkein on building a cancer R&D engine to last.
Ep11: Stephane Bancel
Stephane Bancel, CEO of Moderna Therapeutics, on his influences.
Ep10: Abbie Celniker
Abbie Celniker of Third Rock Ventures on her career, and chipping away at gender inequities in biotech.
Ep9: Bob More
Bob More on biotech venture capital
Ep8: BioMarin History
Daniel Levine & Dan Maher discuss their book "A Rare Breed."
Ep7: Steve Graham
Steve Graham on racism in Corporate America.
Ep6: Steve Holtzman
Ep6: Steve Holtzman of Decibel Therapeutics on political activism among biotech CEOs.
Ep5: Elias Zerhouni
Elias Zerhouni, president of R&D at Sanofi, on immigration in science and the importance of government science funding.
Ep4: Richard Pops
Alkermes CEO Richard Pops on fighting the opioid painkiller crisis.
Ep3: George Yancopoulos
Interview with Regeneron president and CSO George Yancopoulos
Ep2: Katrine Bosley
Ep. 2 of The Long Run With Luke Timmerman. Interview with Katrine Bosley, CEO of Editas Medicine.

Ep1: John Maraganore
Ep. 1 of The Long Run, a biotech podcast with Luke Timmerman. Conversation with Alnylam Pharmaceuticals CEO John Maraganore.